CD44 and breast carcinoma: Indeed, several analyses of human breast carcinomas have revealed TNBCs harbor the highest percentage of CD44+CD24-ALDH1+CSCs, a feature that usually correlates negatively with chemotherapy response, disease-free survival, metastasis-free survival, and overall survival[19].